Gene · 3762
Papers1,500
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,500
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antibiotics and the Endocrine System: Mechanisms, Adverse Effects, and Clinical Implications. | Antibiotics (Basel) | 2026 | 42792007 | PubTator, text mining | PubMed |
| Identification of a novel small-molecule compound that suppresses depolarization-induced CYP11B2 expression and aldosterone production in KCNJ5 mutant adrenocortical cells. | Biochem Biophys Res Commun | 2026 | 42777615 | PubTator, text mining | PubMed |
| A green-fluorogenic, cysteine-reactive dye enables thermal shift-based high-throughput screening with membrane proteins. | J Biol Chem | 2026 | 42754164 | PubTator, text mining | PubMed |
| Tumor-specific KCNJ5 mutation in an aldosterone-producing adenoma not detected in adrenal venous plasma cell-free DNA. | JCEM Case Rep | 2026 | 42666717 | PubTator, text mining | PubMed |
| Macrolide-induced aldosterone suppression as a functional marker of KCNJ5-mutated aldosterone-producing adenoma: a proof-of-concept clinical and experimental study (MAPA study). | Eur J Endocrinol | 2026 | 42663598 | PubTator, text mining | PubMed |
| From bench to bedside: primary aldosteronism revisited. | Endocr Connect | 2026 | 42644335 | PubTator, text mining | PubMed |
| Selective Cell Death of Adrenocortical Cells by Pharmacological Activation of Mutant KCNJ5. | Hypertension | 2026 | 42605674 | PubTator, text mining | PubMed |
| Coexistence of primary aldosteronism and micro-pheochromocytoma: a case report with pathological analysis and literature review. | Front Med (Lausanne) | 2026 | 42559225 | PubTator, text mining | PubMed |
| [Primary aldosteronism as an independent factor of kidney damage. Potential therapeutic strategies and research prospects]. | Probl Endokrinol (Mosk) | 2026 | 42545319 | PubTator, text mining | PubMed |
| KCNJ5-Dependent 68Ga-Pentixafor PET/CT in Primary Aldosteronism Surgery. | J Clin Endocrinol Metab | 2026 | 42531454 | PubTator, text mining | PubMed |
| Current and Novel Biomarkers for Diagnosis and Subtyping of Primary Aldosteronism. | Hypertension | 2026 | 42454396 | PubTator, text mining | PubMed |
| Case Report: A novel MYBPC3 gene variant in a Chinese patient with hypertrophic cardiomyopathy and apical ventricular aneurysm, with a concurrent novel KCNJ5 gene variant. | Front Cardiovasc Med | 2026 | 42428486 | PubTator, text mining | PubMed |
| Multisystemic Assessment in Andersen-Tawil Syndrome: Report of Eighteen Individuals. | Diagnostics (Basel) | 2026 | 42351535 | PubTator, text mining | PubMed |
| Inter- and intratumoral heterogeneity of aldosterone-producing adenomas: recent advances and clinical implications. | Endocr J | 2026 | 42342353 | PubTator, text mining | PubMed |
| Mechanism of Mutation in G Protein-Gated Inwardly Rectifying K+ Channel in Familial Hyperaldosteronism-Type III: Residue Fluctuations and Conformational Instability. | Molecules | 2026 | 42280146 | PubTator, text mining | PubMed |
| Erratum. Unilateral Primary Aldosteronism Lacking KCNJ5 Somatic Mutations Is Associated With an Elevated Risk of New-Onset Diabetes. Diabetes 2025;74:850-859. | Diabetes | 2026 | 42223487 | PubTator, text mining | PubMed |
| Targeting the untargeted: Molecular insights and emerging therapeutic strategies for primary aldosteronism. | Eur J Pharmacol | 2026 | 42208643 | PubTator, text mining | PubMed |
| Aldosterone synthase expression vs cross-sectional imaging in lateralized primary aldosteronism. | J Clin Endocrinol Metab | 2026 | 42089263 | PubTator, text mining | PubMed |
| High-gradient magnetic separation chip-based small extracellular vesicle isolation for noninvasive subtyping of primary aldosteronism. | Sci Adv | 2026 | 41996506 | PubTator, text mining | PubMed |
| Hsa-miR-99a deficiency contributes to MSI-H colorectal cancer progression by activating the mTOR pathway and inducing Th1/Th2 imbalance. | Front Immunol | 2026 | 41924263 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3762/papers